Details

DSEN Abstract: How safe is intravitreal bevacizumab to treat common causes of blindness? Emerging real-world data - CIHR

Metadata and links for an archived snapshot.

Source
Canadian Institutes of Health Research
Date
Apr 10, 2025 · edition #2
Timestamp
2025-04-10T10:50:52.600Z
Language
en
ID
124853
Status
200
Type
text/html

Independent archive · Not an official government website. For up-to-date recommendations, always consult the official source website.

Other snapshots

Archived page preview